The recent resurgence of interest in psychedelic-assisted therapy (PAT) combining the mind-expanding benefits of psychedelic substances with the guidance of a trained therapist culminated in July 2023 when Australia became the first country in the world to approve the use of psylocibin for treatment resistant depression (TRD) and 3,4-Methylene dioxymethamphetamine (MDMA) for post-traumatic stress disorder (PTSD). Media attention has seen a surge in public interest; however, people are met with few options due to a dearth of trained professionals. As such, illegally sourced psychedelic use with unlicensed practitioners, facilitators and shamans currently forms the largest sector of the Australian psychedelic landscape. Therefore, from a harm minimisation perspective, it is vital psychologists understand the psychedelic space and be ready and able to support clients. The aim of the presentation is to develop awareness of the use of psychedelics in the community and to provide education about how clients may present. It will focus on building psychologists confidence and knowledge from a harm minimization perspective. There will be particular emphasis on trauma sensitivity and cultural safety as well as working with challenging "bad trip" experiences. topics include:
• Ethics, regulations and the legal landscape
• Client safety and raising awareness of contraindications to PAT
• Socio-cultural implications of PAT
• Trauma informed practice
• The spiritual nature of psychedelic use
• Therapeutic techniques to help stabilise clients